Delivery Order SPE2DB24D1205-SPE2DB25FCXGJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $78,225.51 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a $14,917.68 delivery order (Contract No. 4569133354) to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 mg/ml pen injectors. The award represents a firm fixed price delivery order with no set-aside designation, indicating competitive procurement. Performance is scheduled to be completed by August 19, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,359.37 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors, with an ultimate completion date of September 10, 2025. This competitive, firm fixed-price delivery order was issued on September 9, 2025, with no set-aside designation, and will be fulfilled at the vendor's Conshohocken, Pennsylvania facility. SKYRIZI is a biologic medication used to treat inflammatory skin conditions, representing one of...
- The Defense Logistics Agency awarded a $12,447.80 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of June 9, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on June 6, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic immunosuppressant medication used to treat inflammatory skin conditions such as plaque...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, valued at $13,637.01 under a firm fixed price contract. The award, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a non-set-aside competitive procurement. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $21,568.25 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors on August 28, 2025. This firm fixed-price, non-set-aside contract represents a single delivery transaction under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with performance in Conshohocken, Pennsylvania and a completion date of June 9, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. SKYRIZI is a biologic immunosuppressant medication used to treat inflammatory skin conditions such as psoriasis and psoriatic arthritis. As a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $15,904.96 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors. This firm fixed price, non-competitive delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. SKYRIZI is a prescription biologic medication used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $31,745.57 to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen injectors on July 24, 2025, with completion targeted for July 25, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's facility in Conshohocken, Pennsylvania. SKYRIZI is a prescription biologic medication used to treat autoimmune and inflammatory conditions, reflecting the federal government's...
- The Defense Logistics Agency awarded a $47,987.95 firm fixed price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen injectors, with an ultimate completion date of August 25, 2025. This non-set-aside competitive award was issued on August 22, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. SKYRIZI is a biologic medication used to treat inflammatory skin conditions, and this delivery order represents a specific...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXGJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen injectors on June 2, 2025, with completion expected by June 3, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million and extending through December 2026. SKYRIZI is a biologic immunosuppressant used to treat moderate-to-severe plaque psoriasis and other inflammatory conditions, making this order part of the broader pharmaceutical supply chain supporting military and federal healthcare systems. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's comprehensive IDC vehicle, which serves as a global pharmaceutical support platform enabling the company to supply a wide range of pharmaceutical products, vaccines, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated consistent capability in fulfilling DLA's medical supply requirements across multiple therapeutic domains through competitively awarded contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 6/2/25 |